Societe Generale’s West Pharmaceutical WST Stock Holding History

Societe Generale’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.6M	Buy	+21,154	New	+$1.54M	0.01%	985

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Societe Generale's WST Position: Q2 2016 in Review

Societe Generale opened a new position in West Pharmaceutical (WST) in Q2 2016: 21,154 shares worth $1.6M. The stake represents 0.01% of the portfolio and ranks #985 among its holdings.

288 funds tracked by Wall St. Rank hold WST as of Q2 2016.

Societe Generale held 21,154 shares of West Pharmaceutical worth $1.6M as of Q2 2016.
West Pharmaceutical was a new Societe Generale position in Q2 2016.
West Pharmaceutical made up 0.01% of Societe Generale's portfolio in Q2 2016, its #985 holding.
288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.